Director/PDMR Shareholding

16^th March 2023

Medcaw Investments Plc - 13078596
(“Medcaw Investments” or the “Company”)

Directors Dealing

Medcaw Investments Plc (LSE:MCI), a special purpose acquisition vehicle, announces that it has received notification that Marcus Yeoman, Non-executive Director, has acquired a total of 95,908 shares in the Company in the following transactions.

Date	Shares acquired	Price per share
14 March 2023	25,000	2.95p
16 March 2023	35,816	3.49p
16 March 2023	25,062	3.99p
16 March 2023	10,030	4.985p

Following the transactions, Marcus Yeoman is interested in 126,808 shares representing  0.74% of the Company’s issued share capital.

This announcement contains inside information for the purposes of UK Market Abuse Regulation.  The persons who arranged the release of this information are the Directors of the Company.

*** ENDS ***

Enquiries:

Medcaw Investments Plc  [phone]

Sarah Cope, Executive Chairperson

Zeus Capital Limited  [phone]

Alexandra Campbell-Harris

1	Details of the person discharging managerial responsibilities
a)	Name	Marcus Yeoman
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Medcaw Investments plc
b)	LEI	213800UTM4MRTZHJ8C21
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each GB00BM8SQP62
b)	Nature of the transaction	Acquisition
c)	Price(s) and volume(s)	Price(s) Volume(s) 2.95p 25,000 3.49p 3.99p 4.985p 35,816 25,062 10,030
d)	Aggregated information -  Aggregated volume  -  Price	95,908 £3,487.45
e)	Date of the transaction	14th to 16th March 2023
f)	Place of the transaction	AIM